<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Pediatric Ophthalmology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Pediatric Ophthalmology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российская педиатрическая офтальмология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1993-1859</issn><issn publication-format="electronic">2412-432X</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">39573</article-id><article-id pub-id-type="doi">10.18821/1993-1859-2018-13-1-21-25</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">ROLE OF OCT-ANGIOGRAPHY IN STUDYING OF PATHOGENESIS, DIAGNOSTICS AND MONITORING THE MACULAR TELANGIECTASIES IN CHILDREN</article-title><trans-title-group xml:lang="ru"><trans-title>РОЛЬ ОКТ-АНГИОГРАФИИ В ИЗУЧЕНИИ ПАТОГЕНЕЗА, ДИАГНОСТИКЕ И МОНИТОРИНГЕ МАКУЛЯРНЫХ ТЕЛЕАНГИЭКТАЗИЙ РАЗЛИЧНОГО ГЕНЕЗА У ДЕТЕЙ И ПОДРОСТКОВ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Katargina</surname><given-names>L. A</given-names></name><name xml:lang="ru"><surname>Катаргина</surname><given-names>Л. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Denisova</surname><given-names>E. V</given-names></name><name xml:lang="ru"><surname>Денисова</surname><given-names>Е. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Osipova</surname><given-names>Natal’ja A.</given-names></name><name xml:lang="ru"><surname>Осипова</surname><given-names>Наталья Анатольевна</given-names></name></name-alternatives><bio xml:lang="en"><p>ophthalmologist of ophthalmology department (pediatric surgery) of The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of Health of the Russian Federation</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, врач-офтальмолог офтальмологического отделения (детской хирургии) ФГБУ «МНИИ ГБ им. Гельмгольца» Минздрава России</p></bio><email>natashamma@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kogoleva</surname><given-names>L. V</given-names></name><name xml:lang="ru"><surname>Коголева</surname><given-names>Л. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tarasenkov</surname><given-names>A. O</given-names></name><name xml:lang="ru"><surname>Тарасенков</surname><given-names>А. О</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belova</surname><given-names>M. V</given-names></name><name xml:lang="ru"><surname>Белова</surname><given-names>М. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novikova</surname><given-names>O. V</given-names></name><name xml:lang="ru"><surname>Новикова</surname><given-names>О. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">The Helmholtz Moscow Research Institute of Eye Diseases of the Ministry of Health</institution></aff><aff><institution xml:lang="ru">ФГБУ «Московский НИИ глазных болезней им. Гельмгольца» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2018</year></pub-date><volume>13</volume><issue>1</issue><issue-title xml:lang="en">VOL 13, NO1 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 13, №1 (2018)</issue-title><fpage>21</fpage><lpage>25</lpage><history><date date-type="received" iso-8601-date="2020-07-22"><day>22</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, ООО "Эко-Вектор"</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ruspoj.com/1993-1859/article/view/39573">https://ruspoj.com/1993-1859/article/view/39573</self-uri><abstract xml:lang="en"><p>The purpose. to assess the potential of OCT-angiography in studying pathogenesis, diagnosing and monitoring macular telangiectasias of various genesis in children and adolescents. Material and methods. We examined and treated 4 children (5 eyes) aged from 12 to 17 years with idiopathic macular telangiectasias (2), developed against the background of Coat’s disease (1) and diabetic retinopathy (1). The examination included standard ophthalmologic inspection, as well as optical coherence tomography and OCT-angiography (RS-3000 Advance AngioSca, Nidek, Japan). Two children underwent transpupillary laser coagulation of telangiectasias (2 and 3 sessions), two received an intravitreal injection of an inhibitor of angiogenesis. Results. Ophthalmoscopically in all children microaneurysms were localized in the macular and paramacular zones and were accompanied by the development of retinal edema. According to OCT-angiography, all children had pathological structural changes (microaneurysms, vascular artery abnormalities, changes in the density of the vascular pattern) of superficial and to a greater extent deep retinal capillary plexuses. As a result of the treatment, 3 children (4 eyes) had clinically noted decrease in the number of microaneurysms. According to the data of optical coherence tomography, there was positive dynamics in decrease of the height of the retinal edema from 49 to 320 μm, аccording to OCT angiography, showed a decrease in the number of microaneurysms in the superficial and especially in the deep plexus, and in a child with diabetic retinopathy there was also a slight increase in the vascular density of the deep capillary plexus. Сonclusion. According to OCT-angiography, development of macular telangiectasias in children is accompanied by preferential changes in the deep capillary plexus, which indicates the pathogenetic significance of microcirculatory disturbances at this level. The method also reveals its value in monitoring the disease.</p></abstract><trans-abstract xml:lang="ru"><p>Цель. Оценка возможностей ОКТ-ангиографии в изучении патогенеза, диагностике и мониторинге макулярных телеангиэктазий различного генеза у детей и подростков. Материал и методы. Нами было обследовано и пролечено 4 ребенка в возрасте от 12 до 17 лет с макулярными телеангиэктазиями идиопатическими (2 ребенка), а также развившимися на фоне болезнь Коатса (1 ребенок) и диабетической ретинопатии (1 ребенок). Обследование включало стандартный офтальмологический осмотр, а также проведение оптической когерентной томографии и ОКТ-ангиографии (RS-3000 Advance AngioSca; Nidek, Japan). Двоим детям была проведена транспупиллярная лазеркоагуляция телеангиэктазий (2 и 3 сеанса), двоим выполнена интравитрельная инъекция ингибитора ангиогенеза. Результаты. Офтальмоскопически у всех детей микроаневризмы локализовались в макулярной и парамакулярной зонах и сопровождались развитием ретинального отека. По данным ОКТ-ангиографии, у всех детей имелись патологические изменения структуры (микроаневризмы, аномалии ветвления сосудов, изменение плотности сосудистого рисунка) поверхностного и, в большей степени, глубокого капиллярных сплетений сетчатки. В результате проведенного лечения у 3 детей (в 4-х глазах) клинически наблюдалось уменьшение числа микроаневризм. По данным ОКТ у этих пациентов отмечалась положительная динамика в виде уменьшения высоты ретинального отека на величину от 49 до 320 мкм, по данным ОКТ-ангиографии выявлялось уменьшение числа микроаневризм в поверхностном и, особенно, в глубоком сплетении, а у ребенка с диабетической ретинопатией отмечалось также и некоторое увеличение сосудистой плотности глубокого капиллярного сплетения. Заключение. По данным ОКТ-ангиографии, развитие макулярных телеангиэктазий у детей сопровождается преимущественными изменениями глубокого капиллярного сплетения сетчатки, что свидетельствует о патогенетическом значении нарушений микроциркуляции на данном уровне. Метод также полезен в мониторинге заболевания.</p></trans-abstract><kwd-group xml:lang="en"><kwd>macular telangiectasias</kwd><kwd>OCT</kwd><kwd>OCT-angiography</kwd><kwd>Coat’s disease</kwd><kwd>diabetic retinopathy</kwd><kwd>ophthalmopediatrics</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>макулярные телеангиэктазии</kwd><kwd>ОКТ</kwd><kwd>болезнь Коатса</kwd><kwd>ОКТ-ангиография</kwd><kwd>офтальмопедиатрия</kwd><kwd>диабетическая ретинопатия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Nowilaty S.R., Al-Shamsi H.N., Al-Khars W. Idiopathic juxtafoveolar retinal telangiectasis: a current review. Middle East Afr. J. Ophthalmol. 2010; 17: 224-41.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Baz Ö., Yılmaz I., Alagöz C., Demircan A., Perente I., Özkaya A., Taşkapılı M. Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia. Turk. J. Ophthalmol. 2017; 47: 144-8. DOI: 10.4274/tjo.04874.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Özkaya A., Yazıcı A.T., Demirok A. Jukstafoveal Telenjiektaziler. Ret.-Vit. 2012; 20: 13-21.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Gass J.D., Blodi B.A. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology. 1993; 100(10): 1536-46.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Yannuzzi L.A., Bardal A.M., Freund K.B., Chen K.J., Eandi C.M., Blodi B. Idiopathic macular telangiectasia. Arch. Ophthalmol. 2006; 124: 450-60.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Wu L., Evans T., Arevalo J.F. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2). Surv. Ophthalmol. 2013; 58(6): 536-59.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Nowilaty S.R., Al-Shamsi H.N., Al-Khars W. Idiopathic juxtafoveolar retinal telangiectasis: a current review. Middle East Afr. J. Ophthalmol. 2010; 17: 224-41.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Park D.W., Schatz H., McDonald H.R., Johnson R.N. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology. 1997; 104: 1838-46.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Alldredge C.D., Garretson B.R. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina. 2003; 23:113-6.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Raza S., Toklu Y., Anayol M.A., Şimşek Ş., Özkan B., Altıntaş A.K. Comparison between efficacy of triamcinolone acetonide and bevacizumab in a case with type 2A idiopathic parafoveal telangiectasia. Turk. J. Ophthalmol. 2011; 41: 6-9.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Roller A.B., Folk J.C., Patel N.M., Boldt H.C., Russell S.R., Abramoff M.D., Mahajan V.B. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia. Retina. 2011; 31: 1848-55.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Kashani A.H., Chen C.L., Gahm J.K., Zheng F., Richter G.M., Rosenfeld P.J., Shi Y., Wang R.K. Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Prog. Retin. Eye Res. 2017; 60: 66-100. doi: 10.1016/j.preteyeres.2017.07.002.</mixed-citation></ref></ref-list></back></article>
